News Quantified

APLT – applied therapeutics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Applied Therapeutics Reports First Quarter 2024 Financial Results [Yahoo! Finance]

Applied Therapeutics Reports First Quarter 2024 Financial Results

Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference

Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer [Yahoo! Finance]

Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer

-1.7%

MISS

Royal Bank of Canada

Royal Bank of Canada

Form 144 Applied Therapeutics, Filed by: Hansard Adam

Form 144 Applied Therapeutics, Filed by: Hansard Adam

Form 10-Q Applied Therapeutics, For: Mar 31

Form 8-K Applied Therapeutics, For: May 09

Form EFFECT Applied Therapeutics,

Top News Gainers

6/10 Applied Therapeutics (NASDAQ: APLT) is now covered by analysts at Robert W. Baird. They set an "outperform" rating on the stock. 6.5%

3/3 Applied Therapeutics Appoints Adam Hansard as Chief Commercial Officer 6.5%

3/13 Form 8-K Applied Therapeutics For: Mar 13 7.0%

1/29 Form 4 Applied Therapeutics For: Jan 28 Filed by: MARCUS JOEL S 7.1%

12/19 Form S-1/A Applied Therapeutics 7.3%

4/3 Form 3 Applied Therapeutics For: Apr 01 Filed by: Mahadevan Chids 9.9%

12/23 Form EFFECT Applied Therapeutics 14.4%

5/13 Form 3 Applied Therapeutics For: May 13 Filed by: Funtleyder Leslie D. 16.9%

1/9 Applied Therapeutics (NASDAQ: APLT) had its price target raised by analysts at Citigroup Inc from $29.00 to $44.00. They now have a "buy" rating on the stock. 25.7%

1/8 Applied Therapeutics Announces Positive Topline Results of Pivotal Phase 2 ACTION-Galactosemia Study of AT-007 in Galactosemia Patients 41.5%

Top News Decliners

8/8 Applied Therapeutics Reports AT-007 SAD Data from Healthy Volunteer Portion of Phase 1/2 ACTION-Galactosemia Study -8.1%

6/5 Form 4 Applied Therapeutics For: Jun 03 Filed by: Funtleyder Leslie D. -9.0%

3/5 Applied Therapeutics (APLT) Investor Presentation - Slideshow [Seeking Alpha] -9.3%

3/31 Form 4 Applied Therapeutics For: Mar 27 Filed by: Alexandria Venture Investments, LLC -10.0%

12/5 Applied Therapeutics Announces Presentations Outlining the Design and Rationale for the ARISE-HF Pivotal Study of AT-001 for Treatment of Diabetic Cardiomyopathy at the 16th Annual Global Cardiovascular Clinical Trialist’s Forum (CVCT) -10.4%

6/21 Applied Therapeutics Reports First Quarter 2019 Financial Results -11.0%

4/21 Applied Therapeutics Announces Full Data and Scientific Presentations from the Pivotal Phase 2 ACTION-Galactosemia Trial -11.8%

3/11 Form 4 Applied Therapeutics For: Mar 09 Filed by: Hansard Adam -11.9%

3/10 Applied Therapeutics (NASDAQ: APLT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -13.2%

3/16 Form POS AM Applied Therapeutics -29.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day